Picture of Cyfuse Biomedical KK logo

4892 — Cyfuse Biomedical KK News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Table: Cyfuse Biomedical - 6-MTH parent results

Aug 14 (Reuters)- 
             Cyfuse Biomedical K.K. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Jun 30, 2023        Jun 30, 2022      Dec 31, 2023  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            18 mln              332 mln           604 mln    
                 (-94.5 pct)                           (+61.5 pct)  
  Operating     loss 363 mln         loss 96 mln      loss 833 mln  
  Recurring     loss 362 mln         loss 76 mln      loss 680 mln  
  Net           loss 364 mln        loss 114 mln      loss 682 mln  
  EPS          loss 46.73 yen      loss 203.61 yen   loss 87.78 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Cyfuse Biomedical K.K.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T

Recent news on Cyfuse Biomedical KK

See all news